Transoral robotic surgery alone for oropharyngeal cancer: quality-of-life outcomes.

Journal: JAMA otolaryngology-- head & neck surgery
Published Date: Jun 1, 2015

Abstract

IMPORTANCE: Few studies have examined quality-of-life (QOL) outcomes in patients who undergo transoral robotic surgery (TORS) alone (ie, without adjuvant radiotherapy or chemoradiotherapy).

Authors

  • Garret W Choby
    Department of Otolaryngology-Head and Neck Surgery, University of Pittsburgh Medical Center Pittsburgh, Pennsylvania.
  • Jeehong Kim
    medical student, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Diane C Ling
    medical student, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Shira Abberbock
    Biostatistics Facility, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania.
  • Rajarsi Mandal
    Department of Otolaryngology-Head and Neck Surgery, University of Pittsburgh Medical Center Pittsburgh, Pennsylvania.
  • Seungwon Kim
    Department of Otolaryngology-Head and Neck Surgery, University of Pittsburgh Medical Center Pittsburgh, Pennsylvania.
  • Robert L Ferris
    Department of Otolaryngology-Head and Neck Surgery, University of Pittsburgh Medical Center Pittsburgh, Pennsylvania.
  • Umamaheswar Duvvuri
    Department of Otolaryngology-Head and Neck Surgery, University of Pittsburgh Medical Center Pittsburgh, Pennsylvania4Department of Otolaryngology, Veterans Affairs Pittsburgh Health System, Pittsburgh, Pennsylvania.

Keywords

External Resources

Popular Topics
Recent Journals